Investment Analysts’ price target changes for Monday, August 7th:

Blue Bird Corporation (NASDAQ:BLBD) was given a $22.00 target price by analysts at Roth Capital. The firm currently has a buy rating on the stock.

Catalyst Pharmaceuticals (NASDAQ:CPRX) was given a $6.00 price target by analysts at Piper Jaffray Companies. The firm currently has a buy rating on the stock.

Corrections Corp. of America (NYSE:CXW) was given a $36.00 target price by analysts at Canaccord Genuity. The firm currently has a buy rating on the stock.

Denison Mines Corp (NYSEMKT:DNN) (TSE:DML) was given a $1.00 price target by analysts at Roth Capital. The firm currently has a buy rating on the stock.

Frank’s International N.V. (NYSE:FI) was given a $8.00 target price by analysts at Piper Jaffray Companies. The firm currently has a hold rating on the stock.

Geo Group Inc (The) (NYSE:GEO) was given a $35.00 price target by analysts at Canaccord Genuity. The firm currently has a buy rating on the stock.

General Mills (NYSE:GIS) was given a $56.00 price target by analysts at Piper Jaffray Companies. The firm currently has a sell rating on the stock.

Horizon Pharma PLC (NASDAQ:HZNP) was given a $18.00 price target by analysts at Piper Jaffray Companies. The firm currently has a buy rating on the stock.

Kellogg (NYSE:K) was given a $78.00 price target by analysts at Piper Jaffray Companies. The firm currently has a buy rating on the stock.

Lipocine (NASDAQ:LPCN) was given a $11.00 price target by analysts at Canaccord Genuity. The firm currently has a buy rating on the stock.

Noble Corporation (NYSE:NE) was given a $4.00 target price by analysts at Piper Jaffray Companies. The firm currently has a hold rating on the stock.

SCYNEXIS (NASDAQ:SCYX) was given a $9.00 price target by analysts at Roth Capital. The firm currently has a buy rating on the stock.

Energy Fuels (NYSEMKT:UUUU) was given a $3.00 price target by analysts at Roth Capital. The firm currently has a buy rating on the stock.

Energous Corporation (NASDAQ:WATT) was given a $23.00 price target by analysts at Roth Capital. The firm currently has a buy rating on the stock.

Zynerba Pharmaceuticals (NASDAQ:ZYNE) was given a $8.00 target price by analysts at Oppenheimer Holdings, Inc.. The firm currently has a buy rating on the stock.

Receive News & Ratings for Blue Bird Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blue Bird Corporation and related companies with MarketBeat.com's FREE daily email newsletter.